Doxylamine succinate and Pyridoxine hydrochloride
These highlights do not include all the information needed to use DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE DELAYED-RELEASE TABLETS. DOXYLAMINE SUCCINATE and PYRIDOXINE HYDROCHLORIDE delayed-release tablets, for oral use Initial U.S. Approval: 1976
0c410285-0ad6-aabc-e063-6294a90abcd8
HUMAN PRESCRIPTION DRUG LABEL
Dec 11, 2023
Bionpharma Inc.,
DUNS: 079637826
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Doxylamine succinate and Pyridoxine hydrochloride
Product Details
FDA regulatory identification and product classification information